ArticleOncotarget2017

Apigenin sensitizes BEL-7402/ADM cells to doxorubicin through inhibiting miR-101/Nrf2 pathway.

Ai-Mei Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.